KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbbVie (ABBV) Profit After Tax (2016 - 2026)

AbbVie has reported Profit After Tax over the past 14 years, most recently at $1.8 billion for Q4 2025.

  • Quarterly Profit After Tax rose 8354.55% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 billion through Dec 2025, down 1.22% year-over-year, with the annual reading at $4.2 billion for FY2025, 1.05% down from the prior year.
  • Profit After Tax was $1.8 billion for Q4 2025 at AbbVie, up from $186.0 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $4.5 billion in Q1 2022 and troughed at -$22.0 million in Q4 2024.
  • The 5-year median for Profit After Tax is $1.5 billion (2024), against an average of $1.8 billion.
  • Year-over-year, Profit After Tax skyrocketed 11133.33% in 2021 and then tumbled 102.68% in 2024.
  • A 5-year view of Profit After Tax shows it stood at $4.0 billion in 2021, then crashed by 38.85% to $2.5 billion in 2022, then plummeted by 66.76% to $822.0 million in 2023, then plummeted by 102.68% to -$22.0 million in 2024, then soared by 8354.55% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Profit After Tax are $1.8 billion (Q4 2025), $186.0 million (Q3 2025), and $938.0 million (Q2 2025).